Olivia Brayer Stock Analyst Profile - Cantor Fitzgerald Research Coverage - Stocknear

Olivia Brayer

Stock Analyst at Cantor Fitzgerald

(4.11)
# 1944
Out of 5,506 analysts
108
Total ratings
Success rate
Average return

17 Stocks

Name Action PT Current % Upside Ratings Updated
CTMX CytomX Therapeutics
Initiates Coverage On: Overweight
6
3.3 81.82% 1 Sep 22, 2025
GOSS Gossamer Bio
Reiterates: Overweight
n/a
n/a n/a 1 Sep 11, 2025
UTHR United Therapeutics
Maintains: Overweight
405 525
453.07 15.88% 2 Sep 10, 2025
VRNA Verona Pharma
Maintains: Overweight
90 100
106.79 -6.36% 1 Jun 11, 2025
VNDA Vanda Pharmaceutical...
Assumes: Overweight
13
5.43 139.41% 1 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
90 90
55.43 62.37% 15 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
480 480
403.12 19.07% 22 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
50 55
45.44 21.04% 9 Feb 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
80 80
112.69 -29.01% 10 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1015 1015
600 69.17% 8 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
405 405
297.89 35.96% 2 Oct 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
220 220
456.35 -51.79% 23 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
10 10
11.35 -11.89% 5 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 7
5.76 12.85% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
72
67.74 6.29% 1 Apr 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
56 21
n/a n/a 2 Feb 23, 2023